Home » Newsletters » BioWorld

BioWorld

July 8, 1993

View Archived Issues

IMMUNE RESPONSE REGISTERS SHARES

XYTRONYX RAISES $1.74 MILLION

TRIPLEX COLLABORATES WITH WISTAR RESEARCHER

VESTAR STARTS TRIALS

INTERLEUKIN SAVES MICE

OXFORD COMPLETES FUND-RAISING

GENICA READIES CMT DIAGNOSTIC

TRIALS OF DENTAL COMPOUND APPROVED

OPPOSITION FORMS AGAINST MEDICAID FORMULARIES

EPA REGISTERS ECOGEN BIOPESTICIDE

COLLABORATIVE SELLS TESTING BUSINESS

AGOURON HALTS TRIALS ON DRUG FOR PSORIASIS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...